MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Infinity Pharmaceuticals Company Profile (NASDAQ:INFI)

Consensus Ratings for Infinity Pharmaceuticals (NASDAQ:INFI) (?)
Ratings Breakdown: 1 Sell Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $14.00 (169.75% upside)

Analysts' Ratings History for Infinity Pharmaceuticals (NASDAQ:INFI)
Show:
DateFirmActionRatingPrice TargetActions
5/10/2016FBR & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016WedbushReiterated RatingUnderperform$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2016RBC CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2016JPMorgan Chase & Co.Reiterated RatingBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$24.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/11/2015William BlairReiterated RatingOutperform$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/21/2015Morgan StanleyUpgradeEqual Weight -> Overweight$15.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015Jefferies GroupSet Price TargetBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2015Stifel NicolausReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2015NomuraReiterated RatingNeutral -> Buy$17.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Deutsche BankInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014Credit SuisseUpgradeNeutral -> Outperform$20.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/3/2014Roth CapitalReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha